Effect of telcagepant on spontaneous ischemia in cardiovascular patients in a randomized study.
Phase of Trial: Phase II
Latest Information Update: 01 Jun 2011
At a glance
- Drugs Telcagepant (Primary)
- Indications Coronary artery disease
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Merck & Co
- 01 Jun 2011 Results published in Headache.
- 05 Nov 2010 New trial record.